Latest news
The Bull Case For Scholar Rock (SRRK) Could Change Following Dual-Track Apitegromab BLA Manufacturing Strategy - simplywall.stsimplywall.st · Thu, 06 Aug 2026 21:57:57 GMTCPC Scientific Announces U.S. FDA Pre-License Inspection (PLI) Successfully Completed at Its Hangzhou cGMP Manufacturing Facility for Hepcludex® API, Establishing a Proven Track Record Under the Stringent BLA Pathway - Business WireBusiness Wire · Wed, 05 Aug 2026 12:11:00 GMTuniQure Reports Q2 2026 Financial Results: AMT-130 BLA on Track, $259M Offering Extends Cash Runway Into 2030 - MinichartMinichart · Wed, 29 Jul 2026 11:25:00 GMTuniQure posts Q2 2026 loss of $81.1M, cash balance $810.3M; BLA for AMT-130 on track - TradingViewTradingView · Wed, 29 Jul 2026 11:13:00 GMT